These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22489659)
1. Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone. Evans-Axelsson S; Ulmert D; Örbom A; Peterson P; Nilsson O; Wennerberg J; Strand J; Wingårdh K; Olsson T; Hagman Z; Tolmachev V; Bjartell A; Lilja H; Strand SE Cancer Biother Radiopharm; 2012 May; 27(4):243-51. PubMed ID: 22489659 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer]. García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948 [TBL] [Abstract][Full Text] [Related]
4. [Experimental studies for immunoscintigraphy of adenocarcinoma of the prostate with 125I-labeled monoclonal antibody to gamma-seminoprotein]. Fujino A; Suyama K; Shidara T; Ao T; Ishibashi A; Koshiba K Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):271-80. PubMed ID: 8121109 [TBL] [Abstract][Full Text] [Related]
5. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555 [TBL] [Abstract][Full Text] [Related]
6. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. Ruggiero A; Holland JP; Hudolin T; Shenker L; Koulova A; Bander NH; Lewis JS; Grimm J J Nucl Med; 2011 Oct; 52(10):1608-15. PubMed ID: 21908391 [TBL] [Abstract][Full Text] [Related]
7. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407 [TBL] [Abstract][Full Text] [Related]
8. Role of Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596 [TBL] [Abstract][Full Text] [Related]
9. 124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results. Zou P; Povoski SP; Hall NC; Carlton MM; Hinkle GH; Xu RX; Mojzisik CM; Johnson MA; Knopp MV; Martin EW; Sun D World J Surg Oncol; 2010 Aug; 8():65. PubMed ID: 20691066 [TBL] [Abstract][Full Text] [Related]
10. Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146. Nurmikko P; Pettersson K; Piironen T; Hugosson J; Lilja H Clin Chem; 2001 Aug; 47(8):1415-23. PubMed ID: 11468231 [TBL] [Abstract][Full Text] [Related]
11. Will Cuccurullo V; di Stasio GD; Evangelista L; Ciarmiello A; Mansi L Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):103-109. PubMed ID: 29422356 [TBL] [Abstract][Full Text] [Related]
12. Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody. van Rij CM; Sharkey RM; Goldenberg DM; Frielink C; Molkenboer JD; Franssen GM; van Weerden WM; Oyen WJ; Boerman OC J Nucl Med; 2011 Oct; 52(10):1601-7. PubMed ID: 21865288 [TBL] [Abstract][Full Text] [Related]
13. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma]. Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489 [TBL] [Abstract][Full Text] [Related]
14. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice. Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631 [TBL] [Abstract][Full Text] [Related]